I wouldn’t mind hearing from @Gumnut70 to give his current thoughts on DEP-Dudetaxel and the wider DEP program.
It was my contention for years that DEP-Dudetaxel was going nowhere, was likely to be a dud and would never commercialised. Gumnut70 however said I was completely clueless on the topic on a number of occasions, and he diligently and in detail explained to the forum why DEP-Dudetaxel was going to be a blockbuster and would revolutionise cancer treatment around the world. Cue a thunderous amount of thumbs up and insight bulbs.
However, subsequent to the recent underwhelming Phase 2 results (which were 5 years late), Starpharma in their webinar update have announced that DEP-Dudetaxel is being de-prioritised.
Just wondering @Gumnut70 (and others), what are your recalibrated thoughts are on the DEP program going forward.
- Forums
- ASX - By Stock
- SPL
- DEP-DUDetaxel
DEP-DUDetaxel
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.73M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.8¢ | $6.156K | 62.05K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22787 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 199768 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22787 | 0.100 |
1 | 97885 | 0.098 |
1 | 64565 | 0.097 |
1 | 50000 | 0.096 |
2 | 60526 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 199768 | 2 |
0.110 | 226808 | 10 |
0.115 | 85453 | 2 |
0.120 | 79405 | 9 |
0.125 | 70120 | 2 |
Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |